Finance

Beta
Lists
NH:NSE
Narayana Hrudayalaya Ltd
₹1,972.00
+1.17%
(+22.80) 1D
Jun 5, 2:11:23 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NH...
Open
₹1,934.30
High
₹1,979.00
Low
₹1,934.30
Mkt. cap
400.51B
Avg. vol.
365.98K
Volume
161.72K
Dividend
0.23%
Quarterly dividend
₹1.12
Ex-dividend date
Jul 17, 2026
P/E ratio
49.16
52-wk high
₹2,370.20
52-wk low
₹1,589.00
EPS
₹40.11
Shares outstanding
204.36M
No. of employees
11K
Open
₹1,934.30
High
₹1,979.00
Low
₹1,934.30
Mkt. cap
400.51B
Avg. vol.
365.98K
Volume
161.72K
Dividend
0.23%
Quarterly dividend
₹1.12
Ex-dividend date
Jul 17, 2026
P/E ratio
49.16
52-wk high
₹2,370.20
52-wk low
₹1,589.00
EPS
₹40.11
Shares outstanding
204.36M
No. of employees
11K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to NH in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for NH in the last 3 months.
Highest
Current ₹1,972.00
₹2,110.00 (+7.00%)
Average
₹2,110.00 (+7.00%)
Lowest
₹2,110.00 (+7.00%)
News stories
From sources across the web
Profile
Narayana Health is an Indian for-profit private hospital network headquartered in Bangalore. It was founded by Dr. Devi Shetty in the year 2000. It operates several hospitals and heart centres across major Indian cities Bangalore, Delhi, Gurugram, Kolkata, Ahmedabad, Raipur, Jaipur, Mumbai, Mysore etc. with an international subsidiary in the Cayman Islands. The facilities offer medical care in over 30 medical specialties and three of its hospitals – Narayana Institute of Cardiac Sciences, Bangalore, and Health City Cayman Islands – are JCI accredited. Wikipedia
About Narayana Hrudayalaya Ltd
CEOEmmanuel Rupert
Employees11.4K
Founded2000
HeadquartersBengaluru, Karnataka, India
SectorHealth care provider
Last report
May 26, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹11.22 / ₹13.05
-14.03%miss
Revenue / Est. (INR)
25.94B / 24.71B
+4.99%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.07B
16.44B
21.51B
25.94B
Cost of goods sold
8.46B
8.76B
11.99B
14.97B
Cost of revenue
8.46B
8.76B
11.99B
14.97B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
4.09B
4.53B
7.07B
7.41B
Total operating expenses
12.55B
13.29B
19.06B
22.38B
Operating income
2.53B
3.15B
2.45B
3.56B
Other non operating income
237.92M
239.92M
232.06M
292.29M
EBT including unusual items
2.31B
2.95B
1.50B
2.92B
EBT excluding unusual items
2.31B
2.95B
2.01B
2.92B
Income tax expense
347.86M
371.93M
222.70M
641.07M
Effective tax rate
15.07%
12.59%
14.81%
21.94%
Other operating expenses
3.25B
3.65B
5.85B
5.87B
Net income
1.97B
2.58B
1.27B
2.24B
Net profit margin
13.05%
15.72%
5.89%
8.63%
Earnings per share
9.65
12.71
8.45
11.22
Interest and investment income
-
-
-
-
Interest expense
-451.63M
-422.60M
-650.33M
-912.85M
Net interest expenses
-451.63M
-422.60M
-650.33M
-912.85M
Depreciation and amortization charges
843.02M
874.76M
1.22B
1.54B
EBITDA
3.23B
4.01B
3.01B
4.69B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more